PT  - JOURNAL ARTICLE
AU  - Shimizu, Kazuki
AU  - Kuniya, Toshikazu
AU  - Tokuda, Yasuharu
TI  - Modelling population-wide screening of SARS-CoV-2 infection for containing COVID-19 pandemic in Okinawa, Japan
AID  - 10.1101/2020.12.19.20248573
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.19.20248573
4099  - http://medrxiv.org/content/early/2020/12/23/2020.12.19.20248573.short
4100  - http://medrxiv.org/content/early/2020/12/23/2020.12.19.20248573.full
AB  - Background To break the chains of SARS-CoV-2 transmission and contain the coronavirus disease 2019 (COVID-19) pandemic, population-wide testing is practiced in various countries. However, scant research has addressed this topic in Japan.Materials and Methods In this modelling exercise, we extracted the number of daily reported cases of COVID-19 in Okinawa from October 1 to November 30, 2020 and explored possible scenarios for decreasing COVID-19 incidence by combining population-wide screening and/or social distancing policy.Results We reveal that permanent lockdown can be replaced by mass testing that mobilizes sufficient target population at an adequate frequency. In addition, solely imposing a circuit breaker will not bring a favorable outcome in the long-term, and mass testing presents implications for minimizing a period of lockdown.Discussion Our results highlight the importance of incentivizing citizens to join the frequent testing and ensure their appropriate isolation. To contain the COVID-19 pandemic, rigorous investment in public health is manifestly vital.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our data were obtained from the public domain and did not include data of individual patients.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur data are available upon request.